Amanta Healthcare IPO GMP: Latest Grey Market Premium, Price, and Full Review
25 August 2025 · Sachin Gadekar
Amanta Healthcare IPO GMP today, issue price, lot size, subscription details, and financial performance.
Introduction
Investors are keeping a close watch on the Amanta Healthcare IPO GMP today, as the pharmaceutical company gears up for its upcoming public issue. Backed by strong domestic and international presence, Amanta Healthcare Limited is offering its shares through a fresh issue worth ₹126 crore.
In this article, we provide a detailed Amanta Healthcare IPO review, covering the IPO date, GMP, price band, lot size, subscription details, financials, and growth prospects.
Amanta Healthcare IPO Key Details
| Particulars | Details |
|---|---|
| IPO Opening Date | September 1, 2025 |
| IPO Closing Date | September 3, 2025 |
| Listing Date (Tentative) | September 9, 2025 |
| Price Band | ₹120 – ₹126 per share |
| Lot Size | 119 shares |
| Issue Size | ₹126 crore (1 crore shares) |
| Issue Type | Book Built IPO |
| Face Value | ₹10 per share |
| Market Lot | 1 lot = 119 shares |
| Listing At | NSE, BSE |
| Registrar | [To be confirmed] |
Amanta Healthcare IPO GMP Today
The Amanta Healthcare IPO GMP (Grey Market Premium) reflects the market’s unofficial sentiment ahead of listing. GMP is essentially the extra price traders are willing to pay for shares in the grey market over and above the IPO issue price.
Amanta Healthcare IPO GMP today: [To be updated daily as per grey market trends]
Expected Listing Gain: Based on the GMP, listing gains could range between 8–15%, subject to demand and overall market conditions.
Tracking the Amanta Healthcare IPO GMP share price helps investors assess the possible listing performance, although it should not be the only factor driving investment decisions.
Amanta Healthcare IPO Lot Size & Investment
| Category | Lots | Shares | Amount (at ₹126) |
|---|---|---|---|
| Retail (Min) | 1 | 119 | ₹14,994 |
| Retail (Max) | 13 | 1,547 | ₹1,94,922 |
| S-HNI (Min) | 14 | 1,666 | ₹2,09,916 |
| S-HNI (Max) | 66 | 7,854 | ₹9,89,604 |
| B-HNI (Min) | 67 | 7,973 | ₹10,04,598 |
About Amanta Healthcare Ltd.
Incorporated in 1994, Amanta Healthcare Ltd. is a leading pharmaceutical company focused on the development, manufacturing, and marketing of sterile liquid formulations and medical devices.
The company specializes in parenteral products (IV fluids, ophthalmic solutions, respiratory care products) packaged using advanced technologies like Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM).
Business Segments:
Domestic Sales – Strong distribution in India with 320 distributors and stockists.
International Sales – Products exported to Africa, Latin America, UK, and other markets.
Product Partnerships – Collaborations with leading Indian and global pharmaceutical companies.
Amanta Healthcare’s products are registered in 19 countries and marketed in 21 international regions, making it a significant player in the global pharmaceutical supply chain.
Competitive Strengths
Wide portfolio of 45+ generic products.
Strong presence in both domestic and international markets.
Advanced manufacturing capabilities with global regulatory compliance.
Experienced management with over 1,700 employees.
Consistent growth in profitability despite revenue fluctuations.
Amanta Healthcare Financial Performance
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | ₹381.76 Cr | ₹352.12 Cr | ₹374.06 Cr |
| Total Income | ₹276.09 Cr | ₹281.61 Cr | ₹262.70 Cr |
| Profit After Tax (PAT) | ₹10.50 Cr | ₹3.63 Cr | -₹2.11 Cr |
| EBITDA | ₹61.05 Cr | ₹58.76 Cr | ₹56.31 Cr |
| Net Worth | ₹96.39 Cr | ₹66.29 Cr | ₹62.88 Cr |
| Total Borrowing | ₹195 Cr | ₹205.23 Cr | ₹215.66 Cr |
Should You Invest in Amanta Healthcare IPO?
The Amanta Healthcare IPO GMP price indicates positive market demand, suggesting decent listing prospects. Strong manufacturing capabilities, diversified product portfolio, and global presence strengthen the company’s fundamentals.
However, investors should also consider:
Debt levels (₹195 Cr borrowings in FY25).
Slight decline in revenue growth.
Dependency on regulatory approvals in international markets.
For investors seeking exposure to the pharmaceutical and healthcare sector, Amanta Healthcare IPO presents a long-term opportunity, with potential listing gains as an additional upside.
FAQs on Amanta Healthcare IPO
Q1. What is Amanta Healthcare IPO GMP today?
Amanta Healthcare IPO GMP today is expected to be updated closer to the issue date. Grey market premium indicates market sentiment ahead of listing.
Q2. What is the Amanta Healthcare IPO price band?
The IPO price band is fixed at ₹120 – ₹126 per share.
Q3. What is the Amanta Healthcare IPO lot size?
The lot size is 119 shares, requiring a minimum investment of ₹14,994 at the upper price band.
Q4. When will Amanta Healthcare IPO open and close?
The IPO will open on September 1, 2025 and close on September 3, 2025.
Q5. When is the Amanta Healthcare IPO listing date?
The IPO is expected to list on September 9, 2025 on NSE and BSE.